Revolutionizing How the Next Generation Treats Geographic Atrophy

This Masterclass is built for retina fellows and early-career specialists who are done with passive learning and ready to gain real-world confidence managing geographic atrophy (GA). It’s not a lecture series, it’s a working lab.

Grounded in evidence, shaped by peer exchange, and refined through hands-on experience, this Masterclass helps build a new clinical recipe for integrating complementary therapy into practice. Apply now, and get ready to work alongside respected retina specialists and peers to break from conventional thinking and learn how to build your own algorithms and lead the future of GA care.

The application deadline is January 1, 2026.

You’ve sat through them before:

• Slide decks without context
• One-way lectures
• Conventional thinking passed down without challenge
• Education that feels more like selling than learning

Our Masterclass was built in response to that fatigue. Instead of telling you what to think, we focus on how you think, decide, adapt, and evolve management protocols for a disease as complex and rapidly evolving as GA.

In medicine, a “recipe” is really an algorithm: a practical, adaptable framework built for real patients, not perfect ones.

This Masterclass helps you:

• Build your own GA treatment algorithms
• Pressure-test decisions through case-based discussion
• Learn from what worked and what didn’t
• Challenge assumptions (yours and your mentors’)

This is interactive, iterative, and unapologetically honest education.

In this Masterclass, mentors act as facilitators rather than lecturers, so you won’t be learning at a distance. 

You’ll be actively contributing and building a community of likeminded caregivers. 

Expect:

✔ Small-group mentorship

✔ Peer-to-peer learning

✔ Live debate and real conversation

✔ Case-based decision making

✔ Open discussion of failed or challenging patient experiences

Four focused online modules (~2 hours each), led by nationally recognized retina experts:

• Pathogenesis of Geographic Atrophy
• Multimodal Diagnostic Strategies for Early Detection & Monitoring
• Safety, Efficacy & Outcomes of Complement Therapy
• Real-World Clinic Flow & Reimbursement Strategies

These modules set the foundation, but they’re just the starting point.

Live sessions designed for:

• Open Q&A
• Literature debate
• Case walkthroughs
• Challenging conventional thinking

Expect conversation, not scripts.

Go beyond abstracts and conclusions:

• Critically evaluate landmark and emerging studies
• Translate trial data into real-world decisions
• Understand where data falls short and what to do when it does

Attendance required.

Includes:

• Half-day case-review grand rounds
• Hands-on wet labs and injection technique workshops
• Small-group discussions focused on real patient scenarios
• Professional development sessions for early-career retina surgeons

This is where theory becomes muscle memory.

• Each learner is paired with a dedicated mentor and small peer group

• Ongoing WhatsApp conversations allow real-time dialogue

• Continued access to modules and webinars for 12 months post-program

• A cohort model that builds lasting professional relationships

This is about building a community, not just completing a course.

This Masterclass is designed for retina specialists who:

Manage 250+ retina patients annually

Are actively using or preparing to implement complement therapy for GA

Want dialogue, challenge, and growth

Practice in a US facility where complement therapy is available

Hotel accommodations provided for March 19 & 20, 2026

All meals provided on 

March 20–21, 2026

Travel scholarships available

Learners are responsible for transportation costs

Participants who complete all program components and pass the final exam will receive:

A Certificate of Completion signed by program leadership and mentors

A Certificate of Commendation awarded to the top 20% of exam scores

But if you’re ready to:

• Challenge conventional thinking
• Build a real-world GA treatment approach you trust
• Learn through discussion, iteration, and honest reflection
• Join a cohort shaping the future of retina care

Applications close January 1, 2026

Click on name to read bio

Click on name to read bio

The John A. Moran Eye Center serves as the Department of Ophthalmology and Visual Sciences at the University of Utah School of Medicine.

It is the largest ophthalmology clinical care and research facility in the Mountain West, with more than 60 faculty members and 10 satellite clinics.

Physicians provide comprehensive care in all ophthalmic subspecialties, making the Moran Eye Center a major referral center for complex cases, with over 150,000 patient visits and about 8,000 surgeries annually.

Moran supports 20 basic and translational research labs and centers, including the Alan S. Crandall Center for Glaucoma Innovation, directed by Iqbal Ike K. Ahmed, MD, FRCSC.

U.S. News & World Report consistently ranks Moran among the Top 10 Best Hospitals for Ophthalmology and Doximity ranks its residency program among the Top 10 nationwide.

Moran CEO and Department of Ophthalmology and Visual Sciences Chair Randall J Olson, MD, leads more than 700 employees working to achieve Moran’s vision that no person with a blinding condition, eye disease, or visual impairment should be without hope, understanding, and treatment. To increase access to care locally and in underserved countries worldwide, Moran runs the largest global outreach program of its kind at any U.S. academic institution.

The Fundingsland Group (TFG) is an independent medical education company that believes in providing compelling, compliant, and effective peer-to-peer education that addresses gaps in clinical knowledge, opinions, and practice patterns. Through a unique, data-driven process, TFG identifies key educational needs and evaluates progress towards meeting clearly defined goals. By strategically collaborating with education partners and industry experts, we create customized education programs that seek to change opinions, affect practice patterns and, ultimately, improve patient care. 

Copyright © 2025 The Fundingsland Group. All rights reserved.